Hallucinations in Parkinson's disease - A study of forty three patients

Journal of Association of Physicians of India

Volumn 52, Issue SEP, 2004, Pages 703-706

  Gupta, Meena ^a   Singh, G ^a   Khwaja, Geeta A ^a   Mehndiratta, M M ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

ARTICLE; COMPARATIVE STUDY; DELUSION; DEPRESSION; FEMALE; HALLUCINATION; HUMAN; INDIA; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGICAL ASPECT; RISK FACTOR; SLEEP DISORDER;

DELUSIONS; DEPRESSION; DOPAMINE AGENTS; FEMALE; HALLUCINATIONS; HUMANS; INDIA; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RISK FACTORS; SLEEP DISORDERS;

EID: 19844370437     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Poewe W, Seppi K. Treatment options for depression and psychosis in Parkinson's disease. J Neurol 2001; 248 Suppl 3: III/12-III/21.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed; Washington, DC: APA, 1998.
3. Barnes J, David AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry 2001;70:727-33.
4. Fenelon G, Mahieux F, Huon R, Ziegler M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 2000;123:733-45.
5. Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-9.
6. Goetz CG, Stebbins GT. Mortality and hallucinations in nursing home patients with advanced Parkinson's disease. Neurology 1995;45:669-71.
7. Meco G, Bonifati V, Cusimano G, Fabrizio E, Vanacore N. Hallucinations in Parkinson's disease: neuropsychological study. Ital J Neurol Sci 1990;11:373-9.
8. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug induced psychiatric states (Review). Adv Neurol 1995;65:115-38.
9. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights (Review). Brain 1998;121:1819-40.
10. Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:434-40.
11. Fahn S, Elton RL. The UPDRS development committee - Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M. editors - Recent developments in Parkinson's disease. Florham Park: Macmillan Health Care Information. 1987;2:153-63.
12. Pillon B, Dubois B, Bonnet AM, Esteguy M, Guimaraes J, Vigouret JM, Lhermitte F, Agid Y. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989;39:762-8.
13. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561-71.
14. Cummings JL. Behavioral complications of drug treatment of Parkinson's disease. J Am Geriatr Soc 1991;39:708-16.
15. Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001;70:734-8.
16. Inzelberg R, Kipervasser S, Korczyn AD. Auditory hallucinations in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998;64:533-5.
17. Moskovitz C, Moses H 3rd, Kllawans HL. Levodopa induced psychosis; a kindling phenomenon. Am J Psychiatry 1978;135:669-75.
18. Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Arch Neurol 1996;53:1265-8.
19. Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999;56:595-601.
20. Manford M, Andermann F. Complex visual hallucinations. Clinical and neurobiological insights (Review). Brain 1998;121:1819-40.
21. Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S. Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 1999;14:117-21.